| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 07/25/2002 | WO2002056826A2 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 07/25/2002 | WO2002056825A2 Composition and method to increase calcium levels in animals |
| 07/25/2002 | WO2002056755A2 Method for treating cancer |
| 07/25/2002 | WO2002056699A1 Coated chewing gum products containing an acid blocker |
| 07/25/2002 | WO2002056692A1 Methods for modulating tumor growth and metastasis |
| 07/25/2002 | WO2002038077A3 L-histidine in ophthalmic solutions |
| 07/25/2002 | WO2002005849A3 Transportation of nucleic acid substances |
| 07/25/2002 | WO2002002063A3 Promoting whole body health |
| 07/25/2002 | WO2001093877A3 Epithelial cell cancer drug |
| 07/25/2002 | WO2001078701A3 Method and compositions for preventing hormone induced adverse effects |
| 07/25/2002 | WO2001074346A3 Sensitization of cells to cytotoxic agents using oligonucleotides directed to nucleotide excision repair or transcritpion coupled repair genes |
| 07/25/2002 | WO2001032186A3 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 07/25/2002 | US20020099100 Treatment of dry eye syndrome |
| 07/25/2002 | US20020099022 Anti-viral composition |
| 07/25/2002 | US20020099020 Oil blend of omega-3- and omega-6- fatty acids; branched amino acid; antioxidant comprising beta-carotene, vitamin C, vitamin E, selenium, or mixtures thereof; in a liquid nutritional matrix. |
| 07/25/2002 | US20020099008 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor |
| 07/25/2002 | US20020098980 Sodium metasilicate, borax, sodium thiosulfate, potassium carbonate, refined sugar, water; improvement in disease resistance, weight gain rate, crop yield, crop quality, harvest time; antibody production and immune enhancement |
| 07/25/2002 | US20020098263 5 ounces each in the morning and evening; safe to be taken with (non) prescription drugs; no side effects |
| 07/25/2002 | US20020098247 May also include cyclooxygenase inhibitor, mucolytic agent (guaifenesin), and salicin-containing herb which facilitates gastrointestinal tract absorption of chromium |
| 07/25/2002 | US20020098246 Treating tumors, lesions, and cancers via delivering peroxide and hypochlorite to target area; drug delivery |
| 07/25/2002 | US20020098205 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 07/25/2002 | US20020098150 Compositions for creating embolic agents and uses thereof |
| 07/25/2002 | US20020098112 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus |
| 07/25/2002 | DE10139401A1 Wound dressing, especially useful for skin grafts, includes an internal chamber with an extension through which a treatment medium can be supplied |
| 07/25/2002 | DE10139400A1 Wound dressing, especially useful for skin grafts, includes an internal chamber with an extension through which a treatment medium can be supplied |
| 07/25/2002 | DE10139398A1 Wound dressing, especially useful for skin grafts, includes an internal chamber with an extension through which a treatment medium can be supplied |
| 07/25/2002 | DE10101522A1 Composition for treating collagenase-linked degenerative diseases, e.g. atherosclerosis, cancer and infections, comprises ascorbate and a fibrinolysis inhibitor |
| 07/25/2002 | CA2435072A1 Dressing material and treatment solution to be used with said dressing material |
| 07/25/2002 | CA2435069A1 Treatment solution for taking care of wounds and dressing material to be used together with said treatment solution |
| 07/25/2002 | CA2434270A1 Use of mesna compounds to prevent adverse reactions to anti-neoplastic compositions |
| 07/25/2002 | CA2433803A1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 07/25/2002 | CA2426799A1 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 07/24/2002 | EP1225238A1 Zinc based alloy bolus for veterinary use |
| 07/24/2002 | EP1224937A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 07/24/2002 | EP1224192A1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer |
| 07/24/2002 | EP1224022A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/24/2002 | EP1223950A2 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 07/24/2002 | EP1223941A2 Therapeutic treatments comprising administratoin of certain steroids for blood cell deficiencies |
| 07/24/2002 | EP1223936A1 Oral formulations for anti-tumor compounds |
| 07/24/2002 | EP1185260A4 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 07/24/2002 | EP0904110B1 Nitric oxide donors capable of reducing toxicity from drugs |
| 07/24/2002 | EP0739210B1 Compositions for local delivery of cytostatic agents |
| 07/24/2002 | CN1360629A Induction of vascular endothelial growth factor (VEGF) by serine/threonine protein kinase AKT |
| 07/24/2002 | CN1360509A Herb medicine composition to be contained in sanitary materials for infants |
| 07/24/2002 | CN1360508A Herb medicine composition to be spread on sanitary napkin for female |
| 07/24/2002 | CN1360494A Delivery system for oral care compositions comprising organosiloxane resins using removable backing strip |
| 07/24/2002 | CN1360493A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1360492A Compositions comprising organosiloxane resins for delivering oral care substances |
| 07/24/2002 | CN1359714A Medicine for treating dermatopathy |
| 07/24/2002 | CN1359684A Pharmaceutical composition for giving up smoking |
| 07/24/2002 | CN1359683A Bactericidal liquid for intramuscular injection, intravenous injection and mixing with blood |
| 07/24/2002 | CN1359671A Process for preparing tablet for quickly setting up bone |
| 07/24/2002 | CN1087939C 碘酸钾制剂 Preparation of potassium iodate |
| 07/23/2002 | US6423742 Synergistic mixture of limonene and gallic acid |
| 07/23/2002 | US6423349 Compositions comprising glutamine in combination with other nutrients, including n-acetyl-cysteine and vitamins a, c, e are disclosed. |
| 07/23/2002 | US6423300 Compositions to control oral microbial oxidation-reduction (Eh) levels |
| 07/23/2002 | CA2256348C Method of improving skin condition |
| 07/18/2002 | WO2002055106A2 Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 07/18/2002 | WO2002055094A1 Injectable hypo-osmolar solution |
| 07/18/2002 | WO2002055093A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 07/18/2002 | WO2002054872A1 Liquid antimicrobial compositions |
| 07/18/2002 | WO2002039978A8 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 07/18/2002 | WO2001056547A3 Preparation of aqueous clear solution dosage forms with bile acids |
| 07/18/2002 | WO2001049295A9 Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification |
| 07/18/2002 | US20020095000 Treatment of dry eye syndrome |
| 07/18/2002 | US20020094996 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 07/18/2002 | US20020094973 Treating an immune-mediated disorder by administering a gold compound and a corticosteroid; antiinflammatory agents; antiproliferative agents; skin disorders; side effect reduction |
| 07/18/2002 | US20020094969 Comprehensive pharmacologic therapy for treatment of obesity including cysteine |
| 07/18/2002 | US20020094948 To treat anemias or hemodialysis patients; individual dosage forms |
| 07/17/2002 | EP1221985A1 Conveyance of anti-infective activity to wound dressings |
| 07/17/2002 | EP1221981A1 Method and apparatus for producing a sterile fluid |
| 07/17/2002 | EP1221965A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 07/17/2002 | EP1221957A2 Method for preparing a composition by mother-of-pearl extraction,and use thereof in cosmetics and dermatology |
| 07/17/2002 | EP1221945A1 Methods, pharmaceutical and therapeutic compositions for administering adenosine |
| 07/17/2002 | EP1066056B1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 07/17/2002 | CN1359296A Use of xenon for treating neurointoxications |
| 07/17/2002 | CN1358536A Medicine for treating lymphatic tuberculosis and lymphoma |
| 07/17/2002 | CN1358521A Liquid medicine for treating beriberi |
| 07/17/2002 | CN1358518A Compound and powder prescription |
| 07/17/2002 | CN1087775C Tech. for culturing spirulina rich in selenium |
| 07/16/2002 | USRE37793 Mixture of bismuth compound and dimercaprol |
| 07/16/2002 | US6420425 Method for the broad based treatment of infections especially infections of organs such as the skin and vagina |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | CA2331185A1 Composition for increasing bone density |
| 07/16/2002 | CA2268773C Skin battery cosmetic composition |
| 07/16/2002 | CA2202397C Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053115A1 Composition used for weaning smokers off the habit |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053094A2 Method for detoxifying a carbohydrate containing solution |
| 07/11/2002 | WO2002028349A3 Method of treating cancer using dithiocarbamate derivatives |
| 07/11/2002 | WO2001049300A3 Combinations for the treatment of dna viral infections comprising a loop diuretic and lithium |
| 07/11/2002 | WO2001049242A3 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside |
| 07/11/2002 | WO2001034125A3 Therapeutic use and formulation of (-)-tramadol |
| 07/11/2002 | US20020091157 Cyclic GMP (cGMP)-specific phosphodiesterase (PDE) inhibitor (e.g., exisulind) to reduce the side effects or increase the efficacy of treatment with an antineoplastic platinum coordination complex like cisplatin or carboplatin. |
| 07/11/2002 | US20020091103 Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder |
| 07/11/2002 | US20020090441 Phytopharmaceutical food products or integrators |
| 07/11/2002 | US20020090419 Food formulations with a high calcium content |
| 07/11/2002 | US20020090401 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 07/11/2002 | US20020090347 For reducing tooth erosion caused by acid |